Clinical and morphological aspects of neoadjuvant chemotherapy efficacy in patients with aggressive luminal HER2-negative breast cancer

Authors: D. A. Morozov, I. V. Kolyadina, I. V. Poddubnaya, I. P. Ganshina, S. V. Khokhlova, V. V. Kometova, V. V. Rodionov

Source: Опухоли женской репродуктивной системы, Vol 17, Iss 4, Pp 38-47 (2022)

Subject Terms: breast cancer, luminal her2-negative subtype, predictor factors for reaching pcr, residual pathomorphological stage of yptn, residual tumor burden according to the rcb system, tils, erlow tumor expression, her low tumor expression, Gynecology and obstetrics, RG1-991

File Description: electronic resource

Relation: https://ojrs.abvpress.ru/ojrs/article/view/894; https://doaj.org/toc/1994-4098; https://doaj.org/toc/1999-8627

Access URL: https://doaj.org/article/48891bdc57a34ef6aade197e0a894a47